YOUNG CHUL Kim

发表

Does Hypercapnic Acidosis, induced by Adding CO2 to Inspired Gas, Have Protective Effect in a Ventilator-induced Lung Injury?

I. Oh, Yu Il Kim, K. S. Kim, 2005, Journal of Korean medical science.

Regulatory variants in cancer-related pathway genes predict survival of patients with surgically resected non-small cell lung cancer.

J. Park, E. Lee, Shin‐Yup Lee, 2018, Gene.

Apoptosis of T Lymphocytes Isolated from Peripheral Blood of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

I. Oh, Yu Il Kim, Yong-Soo Kwon, 2011, Yonsei medical journal.

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

I. Oh, Tae Ok Kim, Yong-Soo Kwon, 2019, Tuberculosis and respiratory diseases.

Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer

Su Yeon Lee, Shin‐Yup Lee, Chang-Min Choi, 2021, Thoracic cancer.

Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population.

Young Chul Kim, Dong Sun Kim, Chang Ho Kim, 2008, Cancer genetics and cytogenetics.

Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion.

K. Na, Yongjik Lee, H. Ahn, 2016, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Paclitaxel-loaded polymeric micelle (230 mg/m(2)) and cisplatin (60 mg/m(2)) vs. paclitaxel (175 mg/m(2)) and cisplatin (60 mg/m(2)) in advanced non-small-cell lung cancer: a multicenter randomized phase IIB trial.

I. Oh, H. Park, Y. Jeon, 2013, Clinical lung cancer.

Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.

J. Park, H. Jeon, Shin‐Yup Lee, 2013, Lung Cancer.

Influence of Diaphragmatic Mobility on Hypercapnia in Patients with Chronic Obstructive Pulmonary Disease

I. Oh, Tae Ok Kim, Yu Il Kim, 2011, Journal of Korean medical science.

Plasma N-terminal Pro-brain Natriuretic Peptide: A Prognostic Marker in Patients with Chronic Obstructive Pulmonary Disease

E. Y. Kim, I. Oh, Yu Il Kim, 2012, Lung.

Plasma C-Reactive Protein and Endothelin-1 Level in Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension

E. Y. Kim, I. Oh, Yong-Soo Kwon, 2010, Journal of Korean medical science.

Re sults of Cu rative Ra diatio n Th erapy w ith or wi tho ut C hem ot herapy fo r Stage III U nresectable N o n-Sm all C ell L ung Ca ncer

Kyu-Sik Kim, T. Nam, S. Ahn, 2005 .

Development of a prognosis‐prediction model incorporating genetic polymorphism with pathologic stage in stage I non‐small cell lung cancer: A multicenter study

E. Lee, Shin‐Yup Lee, J. Choi, 2017, Thoracic cancer.

Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study

I. Oh, K. Na, G. Song, 2016, Journal of Korean medical science.

A Case of Peripheral T Cell Lymphoma Presenting as Severe Hypoxic Respiratory Failure

E. Y. Kim, J. Choi, I. Oh, 2010 .

Analysis of Patients with Hemoptysis in a Tertiary Referral Hospital

I. Oh, Yu Il Kim, Yong-Soo Kwon, 2012, Tuberculosis and respiratory diseases.

BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis.

Y. Chang, E. Y. Kim, A. Kim, 2015, Lung cancer.

Invariant natural killer T cells in chronic obstructive pulmonary disease

I. Oh, Yong-Soo Kwon, H. Ban, 2012, Respirology.

Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease

E. Y. Kim, I. Oh, Yu Il Kim, 2011, The Korean journal of internal medicine.

Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery

Moon Soo Kim, J. Park, E. Lee, 2019, Annals of Surgical Oncology.

Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report

I. Oh, Chang-Min Choi, Tae Ok Kim, 2017, Journal of Korean medical science.

What is Currently the Best for Adenocarcinoma without Driver Mutation?

I. Oh, Cheol-Kyu Park, Young Chul Kim, 2018, Tuberculosis and respiratory diseases.

Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.

J. Park, H. Jeon, Shin‐Yup Lee, 2013, Lung Cancer.

Castleman's disease presenting as a tracheal mass.

I. Oh, Yong-Soo Kwon, K. S. Kim, 2014, The Annals of thoracic surgery.